國立虎尾科技大學 |

Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders/ edited by Paul C. Guest.
other author:	Guest, Paul C.
Description:	XIII, 328 p. 28 illus., 26 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Systems biology. -
Online resource:	https://doi.org/10.1007/978-3-030-05542-4
ISBN:	9783030055424

Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders
Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders[electronic resource] /edited by Paul C. Guest. - 1st ed. 2019. - XIII, 328 p. 28 illus., 26 illus. in color.online resource. - Proteomics, Metabolomics, Interactomics and Systems Biology,11182730-6216 ;. - Proteomics, Metabolomics, Interactomics and Systems Biology,1055.

1. The Potential of ‘Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer’s Disease in African Americans -- 2. The Role of Biomarkers in Alzheimer’s Disease Drug Development -- 3. Mitochondrial Involvement in Mental Disorders; Energy Metabolism, Genetic and Environmental Factors -- 4. Lymphocytes, Platelets, Erythrocytes and Exosomes as Possible Biomarkers for Alzheimer's Disease Clinical Diagnosis -- 5. Genetic Risk Factors for Alzheimer Disease: Emerging Roles of Microglia in Disease Pathomechanisms -- 6. Neuroimaging Studies of Cognitive Function in Schizophrenia -- 7. The Role of Biomarkers in Psychiatry -- 8. Interactome Studies of Psychiatric Disorders -- 9. MicroRNAs in Major Depressive Disorder -- 10. Proteomic Markers for Depression -- 11. Advances in Biomarker Studies in Autism Spectrum Disorders -- 12. Proteomic Investigations of Autism Spectrum Disorder: Past Findings, Current Challenges and Future Prospects -- 13. Role of the Gut Microbiome in Autism Spectrum Disorders -- 14. Metabolomic Biomarkers in Mental Disorders: Bipolar Disorder and Schizophrenia -- 15. Early Detection and Treatment of Patients with Alzheimer’s Disease: Future Perspectives.

This book includes a series of reviews on general aspects of biomarker use in the study of psychiatric and neurodegenerative diseases and the development of medications involved in their treatment. It describes the pros and cons of the various approaches and covers the successes and failures in this research field. It is only by a thorough understanding of the shortcomings that progress can be made. The overall goal is to facilitate the understanding and treatment of these disorders, by providing a viable mechanism of catching up with other areas of modern medicine, such as diabetes and heart disease. Finally, it is anticipated that the development and application of valid biomarker tests and the leveraging of novel drug targets will help the fields of psychiatry on neurodegenerative disorders move into the area of personalized medicine where the right patients can receive the right medication at the right time for the best possible outcome.

ISBN: 9783030055424

Standard No.: 10.1007/978-3-030-05542-4doiSubjects--Topical Terms:

600045
Systems biology.

LC Class. No.: QH301-705

Dewey Class. No.: 570

Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders
LDR:03612nam a22003975i 4500 001 1009849
003 DE-He213
005 20200705055415.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030055424 $9 978-3-030-05542-4
024 7 $a 10.1007/978-3-030-05542-4 $2 doi
035 $a 978-3-030-05542-4
050 4 $a QH301-705
072 7 $a PSA $2 bicssc
072 7 $a SCI086000 $2 bisacsh
072 7 $a PSA $2 thema
082 0 4 $a 570 $2 23
245 1 0 $a Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders $h [electronic resource] / $c edited by Paul C. Guest.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a XIII, 328 p. 28 illus., 26 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Proteomics, Metabolomics, Interactomics and Systems Biology, $x 2730-6216 ; $v 1118
505 0 $a 1. The Potential of ‘Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer’s Disease in African Americans -- 2. The Role of Biomarkers in Alzheimer’s Disease Drug Development -- 3. Mitochondrial Involvement in Mental Disorders; Energy Metabolism, Genetic and Environmental Factors -- 4. Lymphocytes, Platelets, Erythrocytes and Exosomes as Possible Biomarkers for Alzheimer's Disease Clinical Diagnosis -- 5. Genetic Risk Factors for Alzheimer Disease: Emerging Roles of Microglia in Disease Pathomechanisms -- 6. Neuroimaging Studies of Cognitive Function in Schizophrenia -- 7. The Role of Biomarkers in Psychiatry -- 8. Interactome Studies of Psychiatric Disorders -- 9. MicroRNAs in Major Depressive Disorder -- 10. Proteomic Markers for Depression -- 11. Advances in Biomarker Studies in Autism Spectrum Disorders -- 12. Proteomic Investigations of Autism Spectrum Disorder: Past Findings, Current Challenges and Future Prospects -- 13. Role of the Gut Microbiome in Autism Spectrum Disorders -- 14. Metabolomic Biomarkers in Mental Disorders: Bipolar Disorder and Schizophrenia -- 15. Early Detection and Treatment of Patients with Alzheimer’s Disease: Future Perspectives.
520 $a This book includes a series of reviews on general aspects of biomarker use in the study of psychiatric and neurodegenerative diseases and the development of medications involved in their treatment. It describes the pros and cons of the various approaches and covers the successes and failures in this research field. It is only by a thorough understanding of the shortcomings that progress can be made. The overall goal is to facilitate the understanding and treatment of these disorders, by providing a viable mechanism of catching up with other areas of modern medicine, such as diabetes and heart disease. Finally, it is anticipated that the development and application of valid biomarker tests and the leveraging of novel drug targets will help the fields of psychiatry on neurodegenerative disorders move into the area of personalized medicine where the right patients can receive the right medication at the right time for the best possible outcome.
650 0 $a Systems biology. $3 600045
650 0 $a Proteomics. $3 581930
650 0 $a Gene expression. $3 581931
650 1 4 $a Systems Biology. $3 683756
650 2 4 $a Gene Expression. $3 582691
700 1 $a Guest, Paul C. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1139505
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030055417
776 0 8 $i Printed edition: $z 9783030055431
830 0 $a Proteomics, Metabolomics, Interactomics and Systems Biology, $x 2730-6216 ; $v 1055 $3 1285713
856 4 0 $u https://doi.org/10.1007/978-3-030-05542-4
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)